Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?

Elevance Health, Inc. (ELV) is set to report fourth-quarter 2024 results on Jan. 23, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $3.82 per share on revenues of $44.67 billion. See the Zacks Earnings Calendar to stay ahead of market-making news.The fourth-quarter earnings estimate remained stable over the past 30 days. However, the bottom-line projection indicates a year-over-year decline of 32%. The Zacks Consensus Estimate for ...